Breaking News

Olympic Skater Blames Positive Drug Test on Heart Medication Mix-Up

Feb. 16, 2022

Russian determine skater Kamila Valieva claimed her favourable drug exam was brought on by a mix-up with her grandfather’s heart medicine, according to Reuters.

Denis Oswald, the long-lasting chair of the Global Olympic Committee’s disciplinary commission, explained Valieva talked over the blend-up at a Court of Arbitration for Activity listening to, which was convened to figure out regardless of whether she should be permitted to continue on competition.

“Her argument was this contamination took place with a merchandise her grandfather was having,” Oswald explained to reporters.

Valieva, a 15-calendar year-outdated skater for the Russian Olympic Committee, was cleared to compete in the women’s solitary event just after a panel of a few judges agreed with the Russian anti-doping agency’s choice to lift a ban on her.

Having said that, the courtroom did not address the deserves of the drug situation, Reuters noted. The Russian anti-doping company, regarded as RUSADA, will keep a hearing following the Winter Games end.

Valieva was tested at her countrywide championship on Dec. 25. The good final result for the banned angina drug trimetazidine wasn’t unveiled right until Feb. 8, soon after she had presently competed at the Beijing Games in the staff event.

Valieva’s sample involved two other substances that are in some cases employed to assistance the heart but aren’t on the banned list, in accordance to The New York Times. The two substances — hypoxen and L-carnitine — also had been stated on her doping control type.

The discovery of quite a few related substances in an elite athlete, particularly one so youthful, has been cited as unconventional, the newspaper documented.

“It’s a trifecta of substances — two of which are authorized, and a single that is not permitted,” Travis Tygart, the chief executive of the U.S. Anti-Doping Agency, informed the newspaper.

The advantages of that combination “seem to be aimed at raising stamina, minimizing fatigue and marketing greater efficiency,” he mentioned.

The Environment Anti-Doping Company has questioned why RUSADA didn’t respond to the beneficial outcome sooner, Reuters claimed.

Oswald also stated that Valieva’s “B” sample hadn’t but been analyzed, Reuters claimed. Beneath anti-doping principles, an athlete’s urine is tested twice. If the “A” sample is favourable, the testing lab will have to inform the accountable authority, these kinds of as RUSADA in this case.

The athlete can then waive the suitable to have a “B” sample taken but concede to the drug charge. Or else, disciplinary processes just can’t start off right up until equally the “A” and “B” samples are analyzed.

RUSADA also has not responded to inquiries about why Valieva’s “B” sample hasn’t been tested, Reuters described.